(2025) Investigating the Probable Potential of Dihydropyridine Calcium Channel Blockers: Drug Repositioning in Cancer. Current Cancer Therapy Reviews. pp. 950-963. ISSN 15733947 (ISSN)
Full text not available from this repository.
Abstract
In contemporary medicine, cancers are recognized as significant concerns warranting attention. Over time, scientific advancements have assisted physicians worldwide in exploring novel approaches. Among these potential solutions are calcium channel blockers (CCBs), which hold considerable importance and find extensive application across various medical conditions. CCBs, classified as dihydropyridines and non-dihydropyridines, have been widely utilized in the management of diverse cancer types. Given the diverse facets of dihydropyridine CCBs, our objective was to comprehensively gather and summarize pertinent data regarding the impact of this medication class on different cancer types. 2025, Bentham Science Publishers
| Item Type: | Article |
|---|---|
| Keywords: | breast cancer Calcium Channel Blockers (CCBs) cancers dihydropyridines neoplasms ovarian cancer calcium channel blocking agent dihydropyridine dihydropyridine derivative adult controlled study drug repositioning drug therapy electric potential female human male malignant neoplasm review |
| Page Range: | pp. 950-963 |
| Journal or Publication Title: | Current Cancer Therapy Reviews |
| Journal Index: | Scopus |
| Volume: | 21 |
| Number: | 7 |
| Identification Number: | https://doi.org/10.2174/0115733947307639240822120814 |
| ISSN: | 15733947 (ISSN) |
| Depositing User: | خانم ناهید ضیائی |
| URI: | http://eprints.mui.ac.ir/id/eprint/32834 |
Actions (login required)
 |
View Item |